The combination of ATM inhibition and radiotherapy was further shown to increase PDL-1 expression and tumor sensitivity to anti-PDL-1 therapy in a mouse model of pancreatic cancer, accompanied by an increased tumoral infiltration of CD8+ T cells that established immunological memory. Here, ATM is linked to familial pancreatic carcinoma.